New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
New immune system understanding may help doctors target cancer

New immune system understanding may help doctors target cancer

by Garth Sundem,CU Anschutz Medical CampusPaul Norman, PhD. Credit: University of Colorado Cancer CenterYour immune system's natural killer cells recognize and attack two major kinds of dang
Oncology March 12,2024
New immune system understanding may help doctors target cancer

New immune system understanding may help doctors target cancer

by Garth Sundem,CU Anschutz Medical CampusPaul Norman, PhD. Credit: University of Colorado Cancer CenterYour immune system's natural killer cells recognize and attack two major kinds of dang
Oncology March 12,2024
Cellular origins of pediatric brain tumors identified

Cellular origins of pediatric brain tumors identified

by McGill UniversityCredit: CC0 Public DomainA research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with Dr. Nada Jabado
Oncology March 12,2024
Cellular origins of pediatric brain tumors identified

Cellular origins of pediatric brain tumors identified

by McGill UniversityCredit: CC0 Public DomainA research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with Dr. Nada Jabado
Oncology March 12,2024
New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu
Oncology March 12,2024
New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu
Oncology March 12,2024
Targeted therapy slows progression of advanced prostate cancer

Targeted therapy slows progression of advanced prostate cancer

by European Society for Medical OncologyProf Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA, study author Credit: © European Society for Medical
Oncology March 12,2024
Targeted therapy slows progression of advanced prostate cancer

Targeted therapy slows progression of advanced prostate cancer

by European Society for Medical OncologyProf Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA, study author Credit: © European Society for Medical
Oncology March 12,2024
Study analyses how far people will travel for specialist cancer care

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications
Oncology March 12,2024
Study analyses how far people will travel for specialist cancer care

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications
Oncology March 12,2024
Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer
Oncology March 12,2024
Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer
Oncology March 12,2024
Fighting cancer one cell at a time

Fighting cancer one cell at a time

by Agency for Science, Technology and Research (A*STAR), SingaporeDrug-induced stem-cell switch (from Sox2 to Sox9) activates epigenetic re-programming driving tumour evolution in squamous cell c
Oncology March 12,2024
Fighting cancer one cell at a time

Fighting cancer one cell at a time

by Agency for Science, Technology and Research (A*STAR), SingaporeDrug-induced stem-cell switch (from Sox2 to Sox9) activates epigenetic re-programming driving tumour evolution in squamous cell c
Oncology March 12,2024
Meningioma molecular profile reliably predicts tumor recurrence

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The
Oncology March 12,2024
Meningioma molecular profile reliably predicts tumor recurrence

Meningioma molecular profile reliably predicts tumor recurrence

by Baylor College of MedicineCredit: CC0 Public DomainAlthough typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The
Oncology March 12,2024
Anticancer immunity through tumor antigen identification and conversion to DNA vaccines

Anticancer immunity through tumor antigen identification and conversion to DNA vaccines

by The Wistar InstituteCredit: CC0 Public DomainWistar scientists and collaborators demonstrated the utility of an optimized synthetic DNA vaccine platform for rapidly inducing immunity against u
Oncology March 12,2024
Anticancer immunity through tumor antigen identification and conversion to DNA vaccines

Anticancer immunity through tumor antigen identification and conversion to DNA vaccines

by The Wistar InstituteCredit: CC0 Public DomainWistar scientists and collaborators demonstrated the utility of an optimized synthetic DNA vaccine platform for rapidly inducing immunity against u
Oncology March 12,2024
Generating large numbers of universal immune cells could transform cancer immunotherapy

Generating large numbers of universal immune cells could transform cancer immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeA novel method to generate natural killer cells from peripheral blood cell-derived stem cells may transform immunotherapies for d
Oncology March 12,2024
Generating large numbers of universal immune cells could transform cancer immunotherapy

Generating large numbers of universal immune cells could transform cancer immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeA novel method to generate natural killer cells from peripheral blood cell-derived stem cells may transform immunotherapies for d
Oncology March 12,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com